<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03080350</url>
  </required_header>
  <id_info>
    <org_study_id>SABES Pain 2</org_study_id>
    <nct_id>NCT03080350</nct_id>
  </id_info>
  <brief_title>Sublingual Versus Endovenous Fentanyl for the Prehospital Analgesia in Patients With Limb Trauma on the Slope</brief_title>
  <official_title>Sublingual Versus Endovenous Fentanyl for the Prehospital Analgesia in Patients With Limb Trauma on the Slope - a Double-blind Randomized Prospective Study</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Azienda Sanitaria dell'Alto Adige</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Institute of Mountain Emergency Medicine</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Azienda Sanitaria dell'Alto Adige</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of this study is to determine the non-inferiority of the efficacy for prehospital
      analgesia of sublingual administered fentanyl versus endovenous administered fentanyl for
      patients with limb trauma on the slope
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Fentanyl endovenous (ev) is an excellent analgesic drug for pain relief in acute traumatic
      pain. Fentanyl sublingual (Abstral ®) is an excellent analgesic drug in the breakthrough
      cancer pain relief in oncologic patients.

      The immediate (less than 10 minutes) effect and the ease of administration of sublingual
      fentanyl is a feasible drug administration for immediate analgesia in remote areas such as
      mountain rescue missions eg. the slope.

      Patients will be recruited according to a randomized list to fentanyl ev or fentanyl
      sublingual versus placebo oral or placebo ev.

      Safety issues like control of vital signs will be warranted.
    </textblock>
  </detailed_description>
  <overall_status>Active, not recruiting</overall_status>
  <start_date type="Actual">January 2017</start_date>
  <completion_date type="Anticipated">November 2018</completion_date>
  <primary_completion_date type="Actual">March 2018</primary_completion_date>
  <phase>Phase 4</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Triple (Participant, Care Provider, Investigator)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Pain - Relief</measure>
    <time_frame>1 hour</time_frame>
    <description>Pain - Relief of 2 points on a 11 items pain scale (0 = non pain; 10 = unbearable pain)</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Practicability / handling of the two dosage forms of fentanyl in emergencies</measure>
    <time_frame>1 hour</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Patient comfort</measure>
    <time_frame>1 hour</time_frame>
    <description>5 items Labert Scale</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Adverse drug effects</measure>
    <time_frame>1 hour</time_frame>
    <description>such as pruritus, nausea, dizziness</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>SpO2 (%)</measure>
    <time_frame>1 hour</time_frame>
    <description>SpO2 &lt; 92%</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">108</enrollment>
  <condition>Acute Pain Due to Trauma</condition>
  <arm_group>
    <arm_group_label>Fentanyl sublingual + Placebo ev</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Fentanyl 100 µg sublingual in acute sever pain + NaCl 0,9% endovenous to mimic fentanyl ev</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Fentanyl ev + Placebo sublingual</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Fentanyl ev in acute sever pain + Sugar pill manufactured to mimic fentanyl sublingual</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Fentanyl sublingual</intervention_name>
    <description>Fentanyl sublingual</description>
    <arm_group_label>Fentanyl sublingual + Placebo ev</arm_group_label>
    <other_name>Abstral</other_name>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Fentanyl ev</intervention_name>
    <description>Fentanyl ev</description>
    <arm_group_label>Fentanyl ev + Placebo sublingual</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Placebo sublingual</intervention_name>
    <description>Placebo sublingual</description>
    <arm_group_label>Fentanyl ev + Placebo sublingual</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Placebo ev</intervention_name>
    <description>Placebo - NaCL 0,9% ev</description>
    <arm_group_label>Fentanyl sublingual + Placebo ev</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Trauma on the limbs with a pain score of 4 or more on the slope

          -  ASA I - II

        Exclusion Criteria:

          -  children (&lt; 18 years)

          -  cognitive impairment: brain injury, intoxication, analgesia

          -  weight under 50 kg and more than 100 kg

          -  other injuries like chest trauma with respiratory insufficiency, suspect liver or
             spleen injury, amputation;

          -  chronic analgesic use or misuse

          -  allergy

          -  fear of needles

          -  pregnancy

          -  speech difficulties
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Rosmarie Oberhammer, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Südtiroler Sanitätsbetrieb - Bruneck Hospital</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Skiresort - Kronplatz</name>
      <address>
        <city>Bruneck</city>
        <zip>39031</zip>
        <country>Italy</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Italy</country>
  </location_countries>
  <verification_date>April 2018</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>December 4, 2016</study_first_submitted>
  <study_first_submitted_qc>March 9, 2017</study_first_submitted_qc>
  <study_first_posted type="Actual">March 15, 2017</study_first_posted>
  <last_update_submitted>April 19, 2018</last_update_submitted>
  <last_update_submitted_qc>April 19, 2018</last_update_submitted_qc>
  <last_update_posted type="Actual">April 20, 2018</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Azienda Sanitaria dell'Alto Adige</investigator_affiliation>
    <investigator_full_name>Elisabeth Gruber</investigator_full_name>
    <investigator_title>MD</investigator_title>
  </responsible_party>
  <keyword>Fentanyl</keyword>
  <keyword>Transmucosal administration</keyword>
  <keyword>Endovenous administration</keyword>
  <keyword>Pain therapy</keyword>
  <keyword>Mountain emergency medicine</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Wounds and Injuries</mesh_term>
    <mesh_term>Acute Pain</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Fentanyl</mesh_term>
  </intervention_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

